Wales to play major role in national trial for COVID-19 vaccine

A leading university

in the heart of a
thriving capital city


95 %

of our undergraduates enter employment or further study shortly after graduating

(HESA 2016/17)

Top 5

UK University for
research quality

(REF 2014)

Welcoming and ambitious

we are truly a global

600 m

invested in our biggest

Working to make

a better future

for Wales and the world

Wales will play a vital role in finding a way out of the coro rus pandemic as part of the next phase of a UK-led study.

The University’s Centre for Trials Research is part of a collaboration co-ordinated by Health and Care Research Wales and involving Public Health Wales and Aneurin Bevan University Health Board, that will take part in the next phase of the vaccine trial sponsored by the University of Oxford and funded by CEPI (Coalition for Epidemic Preparedness Innovations) UK Research and Innovation.

Public Health Wales will lead the recruitment of 500 participants within Aneurin Bevan University Health Board for the Oxford Vaccine Group COVID-19 vaccine trial.

The aim is to find a safe vaccine that will develop immunity against the virus and thus prevent the disease. The study aims to recruit 10,000 participants overall.

COVID-19 vaccine development is a vital part of the long-term response to the coro rus pandemic and Wales will be joined by multiple other sites across the UK as part of phase 2/3 of the study.

This phase of the trial is not open to members of the public.

Volunteers will be staff aged 18 and over working within health and care within the Aneurin Bevan University Health Board area. This will include hospitals, GP practices, pharmacy, physiotherapy, community care and other non-clinical professions within secondary care who are deemed at risk of exposure to coro rus. Eligible participants will receive details from the health board about how to participate if they wish.

Dr Chris Williams, Principal Investigator for Public Health Wales and lead for the vaccine trial in Wales, said: “This is an important study to test the effectiveness of one of the main candidate vaccines for COVID-19 in Wales."

Professor Sue Bale, Director of Research and Development at Aneurin Bevan University Health Board, said: “Finding a vaccine for COVID-19 is thought to be the only way in which we can start to return to any degree of normality as a society. Scientists at Oxford University have developed a vaccine and the Health Board has the exciting opportunity for 500 of our staff to take part in this fantastic trial.”

Professor Kieran Walshe, Director of Health and Care Research Wales, which is nationally co-ordinating research and study-set up in Wales, said: “Research is absolutely vital to finding new ways to deal with COVID-19 and its impact on health and care, and a vaccine is the ultimate goal. I am proud that researchers in Wales are working with national partners to find the most effective treatments, and to trial the Oxford vaccine here in Wales. Our research community and our health and care staff, are making a real difference to finding a lasting solution to the COVID-19 pandemic.”

Professor Kerry Hood, Director of the Centre for Trials Research at Cardiff University said: “We are delighted to be able to build on our previous collaborations with Public Health Wales and Aneurin Bevan University Health Board to help them to set up this vitally important vaccine trial. Usually a study like this would take months to set up, but with such a dedicated, skilled team working across organisational boundaries has achieved an amazing feat. This is a mighty step for research, even if it is only what may seem a small step in our national response to COVID-19.”

This site uses cookies and analysis tools to improve the usability of the site. More information. |